The Evolution of Antipsychotic Drug Therapy: Reserpine, Chlorpromazine, and Haloperidol
Author:
- 1 July 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Psychiatric Practice
- Vol. 13 (4) , 253-257
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Drug-Drug Interactions: Proof of Relevance (Part II): Cause of Tolerability Problems or NoncomplianceJournal of Psychiatric Practice, 2005
- Comments on the Role of Therapeutic Drug Monitoring for ClozapineJournal of Psychiatric Practice, 2005
- Clinical Application of the Concept of Relative Potency: An Example Involving Chlorpromazine and HaloperidolJournal of Psychiatric Practice, 2005
- Drug-Drug Interactions: Proof of Relevance (Part I)Journal of Psychiatric Practice, 2005
- Classification of Neuropsychiatric Medications by Principal Mechanism of Action: A Meaningful Way to Anticipate Pharmacodynamically Mediated Drug Interactions (Part II)Journal of Psychiatric Practice, 2004
- Classification of Neuropsychiatric Medications by Principal Mechanism of Action: A Meaningful Way to Anticipate Pharmacodynamically Mediated Drug InteractionsJournal of Psychiatric Practice, 2003
- Antipsychotic Drug Development in the Pre-Human-Genome Era: A Full CircleJournal of Psychiatric Practice, 2001
- Peptides and Psychiatry, Part 1: How Synthesis of Neuropeptides Differs From Classical Neurotransmitter SynthesisThe Journal of Clinical Psychiatry, 1999
- Dissimilar dosing with high-potency and low-potency neurolepticsAmerican Journal of Psychiatry, 1984
- On the constitution of reserpine fromRauwolfia serpentina benthCellular and Molecular Life Sciences, 1953